Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611) von Tallarico, Michael, Foster, Jared C., Seisler, Drew, Lafky, Jacqueline M., Hurria, Arti, Jatoi, Aminah, Cohen, Harvey J., Muss, Hyman B., Bartlett, Nancy, Cheson, Bruce D., Jung, Sin-Ho, Leonard, John P., Byrd, John C., Nabhan, Chadi

Volltext

Soluble Epidermal Growth Factor Receptor (sEGFR/sErbB1) as a Potential Risk, Screening, and Diagnostic Serum Biomarker of Epithelial Ovarian Cancer von Baron, Andre T, Cora, Elsa M, Lafky, Jacqueline M, Boardman, Cecelia H, Buenafe, Marites C, Rademaker, Alfred, Liu, Dachao, Fishman, David A, Podratz, Karl C, Maihle, Nita J

Volltext

Soluble Epidermal Growth Factor Receptor (SEG-FR) and Cancer Antigen 125 (CA125) as Screening and Diagnostic Tests for Epithelial Ovarian Cancer von BARON, Andre T, BOARDMAN, Cecelia H, LAFKY, Jacqueline M, RADEMAKER, Alfred, DACHAO LIU, FISHMAN, David A, PODRATZ, Karl C, MAIHLE, Nita J

Volltext

A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer von Perez, E. A., Geeraerts, L., Suman, V. J., Adjei, A. A., Baron, A. T., Hatfield, A. K., Maihle, N., Michalak, J. C., Kuross, S. A., Kugler, J. W., Lafky, J. M., Ingle, J. N.

Volltext

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole von LAFKY, Jacqueline M, BARON, Andre T, CORA, Elsa M, HILLMAN, David W, SUMAN, Vera J, PEREZ, Edith A, INGJE, James N, MAIHLE, Nita J

Volltext

Serum biomarker analysis in a phase II study of irinotecan in refractory metastatic breast cancer (MBC) von Moreno-Aspitia, A, Anderson, KS, Reinholz, MM, Lipton, A, Carney, W, Dueck, AC, Lafky, JM, Fitch, TR, Hillman, DW, Perez, EA

Volltext

Serum sErbB1 and Epidermal Growth Factor Levels As Tumor Biomarkers in Women with Stage III or IV Epithelial Ovarian Cancer von Baron, A T, Lafky, J M, Boardman, C H, Balasubramaniam, S, Suman, V J, Podratz, K C, Maihle, N J

Volltext

A Preliminary Study of Serum Concentrations of Soluble Epidermal Growth Factor Receptor (sErbB1), Gonadotropins, and Steroid Hormones in Healthy Men and Women von BARON, Andre T, LAFKY, Jacqueline M, SUMAN, Vera J, HILLMAN, David W, BUENAFE, Marites C, BOARDMAN, Cecelia H, PODRATZ, Karl C, PEREZ, Edith A, MAIHLE, Nita J

Volltext

Soluble Epidermal Growth Factor Receptor (sEGFR) and Cancer Antigen 125 (CA 125) as Screening and Diagnostic Tests for Epithelial Ovarian Cancer

Volltext

A sandwich type Acridinium-Linked ImmunoSorbent Assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera von Baron, Andre T, Lafky, Jacqueline M, Connolly, Denise C, Peoples, Jennifer, O'Kane, Dennis J, Suman, Vera J, Boardman, Cecelia H, Podratz, Karl C, Maihle, Nita J

Volltext

The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer von JONES, Monica Brown, HOUWINK, Aletta P, FREEMAN, Brandi K, GREENWOOD, Tammy M, LAFKY, Jacqueline M, LINGLE, Wilma L, BERCHUCK, Andrew, MAXWELL, G. Lawrence, PODRATZ, Karl C, MAIHLE, Nita J

Volltext

Monoclonal antibodies specific for peptide epitopes of the Epidermal Growth Factor Receptor's extracellular domain von BARON, A. T, HUNTLEY, B. K, LAFKY, J. M, REITER, J. L, LIEBENOW, J, MCCORMICK, D. J, ZIESMER, S. C, ROCHE, P. C, MAIHLE, N. J

Volltext